Hydroxyamine

Hydroxyamine

SCHEMBL4807777

NO.O=C(O)c1ccc2cc(Cc3ccc4ccccc4c3)[nH]c2c1

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
CHEK2 O96017 1/20 0.47
F2 P00734 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NR1H4 Q96RI1 2/20 0.44
PIN1 Q13526 1/20 0.43
ITK Q08881 2/20 0.42
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
ACHE P22303 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.40
MLKL Q8NB16 1/20 0.40
TBXA2R P21731 1/20 0.40
PTGER4 P35408 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydroxyamine SCHEMBL5144256 0.84 KDM4A (0.50) CASP3SENP8SENP7SENP6CHEK2
SCHEMBL4796231 0.84 HDAC6 (0.54) CHEK2NR1H4PIN1ITK
Hydroxyamine SCHEMBL4796191 0.83 NR4A2 (0.46) CASP3SENP8SENP7SENP6CHEK2
Hydroxyamine SCHEMBL4795956 0.82 PDE5A (0.52) CASP3SENP8SENP7SENP6CHEK2
SCHEMBL4803301 0.80 SRD5A2 (0.51) CASP3SENP8SENP7SENP6F2
Hydroxyamine SCHEMBL5618267 0.80 MRGPRX4 (0.46) CASP3SENP8SENP7SENP6CHEK2
SCHEMBL6991892 0.79 LOXL2 (0.55)
Hydroxyamine SCHEMBL4796509 0.78 LMNA (0.53) MEN1KMT2AHTTACHEMRGPRX4
Hydroxyamine SCHEMBL4802770 0.76 TUBB4A (0.41) CASP3SENP8SENP7SENP6HTT
SCHEMBL977626 0.75 F2 (0.70) CASP3SENP8SENP7SENP6F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008061160-A1 USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS PHARMACYCLICS, INC. (US) 2008-05-22 WO disclosed